M&A LabNovember 13, 2008 Ranbaxy-Daiichi Deal DissectedDear All, With the completion of acquisition of 63.92% equity stake in Ranbaxy Laboratories Limited (“Ranbaxy”), India's largest pharmaceutical company, by Japanese pharma major Daiichi Sankyo Co., Ltd. (“Daiichi”), on November 7, 2008, it would be interesting to analyze the key legal and tax issues that arose from the beginning till the completion of this landmark deal. For a detailed analysis of the legal and tax issues, please click here for the document. As you would be aware, we have been providing regular information on latest legal developments. M&A Lab is our latest initiative to provide you in depth and knowledge based analysis of latest M&A deals. We will be happy to have your views / comments on our initiative.
DisclaimerThe contents of this hotline should not be construed as legal opinion. View detailed disclaimer. |
|